Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis

Guangli Ma; Rujia Xie; Bruce Strober; Richard Langley; Kaori Ito; Sriram Krishnaswami; Robert Wolk; Hernan Valdez; Scott Rottinghaus; Anna Tallman; Pankaj Gupta

doi:10.1002/cpdd.471

Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis

Guangli Ma, Rujia Xie, Bruce Strober, Richard Langley, Kaori Ito, Sriram Krishnaswami, Robert Wolk, Hernan Valdez, Scott Rottinghaus, Anna Tallman, Pankaj Gupta

Inernational Relations Division

科研成果: 期刊稿件 › 文章 › 同行评审

14 引用（Scopus）

源语言	英语
页（从-至）	587-596
页数	10
期刊	Clinical Pharmacology in Drug Development
卷	7
期	6
DOI	https://doi.org/10.1002/cpdd.471
出版状态	已出版 - 8月 2018

!!!ASJC Scopus Subject Areas

药学（医学）
药物科学

访问文件

10.1002/cpdd.471

其它文件与链接

引用此

@article{31b79ac6c554424184ee5eda7fd3d033,

title = "Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis",

keywords = "Janus kinase inhibitor, chronic plaque psoriasis, population pharmacokinetics, tofacitinib",

author = "Guangli Ma and Rujia Xie and Bruce Strober and Richard Langley and Kaori Ito and Sriram Krishnaswami and Robert Wolk and Hernan Valdez and Scott Rottinghaus and Anna Tallman and Pankaj Gupta",

note = "Publisher Copyright: {\textcopyright} 2018, The American College of Clinical Pharmacology",

year = "2018",

month = aug,

doi = "10.1002/cpdd.471",

language = "English",

volume = "7",

pages = "587--596",

journal = "Clinical Pharmacology in Drug Development",

issn = "2160-763X",

publisher = "Sage Periodicals Press",

number = "6",

}

TY - JOUR

T1 - Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis

AU - Ma, Guangli

AU - Xie, Rujia

AU - Strober, Bruce

AU - Langley, Richard

AU - Ito, Kaori

AU - Krishnaswami, Sriram

AU - Wolk, Robert

AU - Valdez, Hernan

AU - Rottinghaus, Scott

AU - Tallman, Anna

AU - Gupta, Pankaj

PY - 2018/8

Y1 - 2018/8

KW - Janus kinase inhibitor

KW - chronic plaque psoriasis

KW - population pharmacokinetics

KW - tofacitinib

UR - http://www.scopus.com/inward/record.url?scp=85050485919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050485919&partnerID=8YFLogxK

U2 - 10.1002/cpdd.471

DO - 10.1002/cpdd.471

M3 - Article

C2 - 29856518

AN - SCOPUS:85050485919

SN - 2160-763X

VL - 7

SP - 587

EP - 596

JO - Clinical Pharmacology in Drug Development

JF - Clinical Pharmacology in Drug Development

IS - 6

ER -

Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此